-+ 0.00%
-+ 0.00%
-+ 0.00%

Brenntag Pharma partners with Evonik for exclusive REXIM GMP amino acids distribution in Europe

PUBT·07/15/2026 08:55:49
Listen to the news
Brenntag Pharma partners with Evonik for exclusive REXIM GMP amino acids distribution in Europe
  • Brenntag Pharma entered a strategic partnership with Evonik for exclusive distribution of REXIM GMP pharmaceutical-grade amino acids across most of Europe.
  • Agreement took effect July 1, 2026; Brenntag assumes responsibility for market development, distribution, local service, technical support, supply security.
  • Deal targets pharmaceutical, biopharmaceutical markets; strengthens Brenntag’s positioning in biopharma, API ingredients distribution.
  • Coverage includes key European markets; excludes Italy, Ukraine, Middle East, Africa.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Brenntag SE published the original content used to generate this news brief on July 15, 2026, and is solely responsible for the information contained therein.